Clinical Trial Update: Treatment of Primary Peritoneal Carcinosis of Digestive Origin Using Cytoreductive Surgery and Hyperthermic Intraoperative Peritoneal Chemotherapy With Mitomycin C and Irinotecan [Phase 1, Phase 2]

View source ↗

Summary

This trial update reports completion of a Phase 1/Phase 2 study evaluating cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy with mito…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peritoneal Carcinomatosis

Drugs mentioned

• Camptosar (irinotecan)
• Mitomycin-C (mitomycin C)

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Peritoneal Carcinosis (PC) | Phase 1, Phase 2 | Status: COMPLETED